Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-18-016992

Chief Financial Officer gave up 8,208 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Myszkowski Kenneth Allen Chief Financial Officer 2018-03-05 Shares withheld for taxes −8,208 $6.66 $54,665 310,815 D
Loading xslF345X03/doc4.xml…